European Commission approves Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resected Stage II-III NSCLC, compared with best supportive care Tecentriq is now the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe Today’s approval marks Tecentriq’s sixth […]
U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)
FoundationOne CDx can now be used to identify patients with ROS1 fusion-positive non-small cell lung cancer or patients with NTRK fusion-positive solid tumours for whom treatment with Rozlytrek may be appropriate This approval marks the first and only companion diagnostic indication for Rozlytrek, and another important milestone in tumour-agnostic approaches for people living with rare […]
European Commission approves Roche’s first-in-class bispecific antibody Lunsumio for people with relapsed or refractory follicular lymphoma
Lunsumio® (mosunetuzumab) is the first CD20xCD3 T-cell engaging bispecific antibody available to treat the most common slow-growing form of non-Hodgkin lymphoma, follicular lymphoma (FL) Lunsumio represents a new type of immunotherapy that is a chemotherapy-free, off-the-shelf, fixed-duration treatment option that could improve outcomes for people who have relapsed or are refractory to multiple previous treatments […]
Multi-country monkeypox outbreak: situation update
Since 13 May 2022, and as of 2 June 2022, 780 laboratory confirmed cases of monkeypox have been reported to or identified by WHO from 27 Member States across four WHO regions that are not endemic for monkeypox virus. Epidemiological investigations are ongoing. Most reported cases so far have been presented through sexual health or […]
WHO consultation sets research priorities for monkeypox
A global research consultation convened by the WHO R&D Blueprint gathered over 500 experts and more than 2000 participants to discuss knowledge gaps and research priorities for monkeypox, in view of the recent outbreaks of the disease in both endemic and non-endemic countries. Researchers and high-level experts from all over the world met virtually for […]
‘eSanjeevani’, Govt. of India’s free Telemedicine service integrated with NHA’s Ayushman Bharat Digital Mission (ABDM)
The National Health Authority (NHA) announces the successful integration of eSanjeevani with its flagship scheme – Ayushman Bharat Digital Mission (ABDM). This integration allows the existing users of eSanjeevani, the telemedicine service of Ministry of Health and Family Welfare (MoHFW) to easily create their Ayushman Bharat Health Account (ABHA) and use it to link and […]
Dr. Mansukh Mandaviya interacts with Officials of regional PIB, DD, AIR and regional media persons; appreciates their crucial role during COVID Pandemic
“For a Samruddh Bharat, we need a Swasthya Bharat and for a Swasthya Bharat, we need Swasthya Nagrik. Health has been positioned at the centre-stage by PM Shri Narendra Modi ji, and several health initiatives are being taken up by the Union Government. India is also ready to for a leading global to provide healthcare […]
One hundred days of war has put Ukraine’s health system under severe pressure
After one hundred days of war, Ukraine’s health system is under severe pressure and the World Health Organization (WHO) has increased its presence, both in Ukraine and in those countries hosting displaced Ukrainians, to help meet the escalating health needs. “This war has gone on for 100 days too many, shattering lives and communities, and […]
Why mental health is a priority for action on climate change
Climate change poses serious risks to mental health and well-being, concludes a new WHO policy brief, launched today at the Stockholm+50 conference. The Organization is therefore urging countries to include mental health support in their response to the climate crisis, citing examples where a few pioneering countries have done this effectively. The findings concur with […]
Interim statement on hybrid immunity and increasing population seroprevalence rates
The World Health Organization (WHO) with the support of the Strategic Advisory Group of Experts (SAGE) on Immunization and its COVID-19 Vaccines Working Group, continues to review the emerging evidence on the increasing seroprevalence rates against SARS-CoV-2 globally and the characteristics and potential benefits of hybrid immunity. This statement reflects the current understanding of hybrid […]
